Your browser doesn't support javascript.
loading
Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan-cancer analysis.
Wang, Jing; Dai, Mingkai; Xing, Xiangling; Wang, Xing; Qin, Xin; Huang, Tao; Fang, Zhiqing; Fan, Yidong; Xu, Dawei.
Affiliation
  • Wang J; Department of Urologic Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Dai M; Division of Hematology, Department of Medicine, Bioclinicum and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.
  • Xing X; Division of Hematology, Department of Medicine, Bioclinicum and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.
  • Wang X; Department of Urology Surgery, The First Affiliated Hospital of USTC, Wannan Medical college, Wuhu, China.
  • Qin X; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Huang T; Department of Urologic Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Fang Z; Department of Urology Surgery, The First Affiliated Hospital of USTC, Wannan Medical college, Wuhu, China.
  • Fan Y; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
  • Xu D; Department of Urology, Qilu Hospital of Shandong University, Jinan, China.
Mol Oncol ; 17(1): 150-172, 2023 01.
Article de En | MEDLINE | ID: mdl-36239411

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Telomerase / Tumeurs Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Oncol Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Telomerase / Tumeurs Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Mol Oncol Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique